InvestorsHub Logo
icon url

BTH

01/05/11 1:43 PM

#4616 RE: poorgradstudent #4615

As Ariad's secondary endpoint is OS, wouldn't shareholders be waiting years for those results?
BTW, thanks for your responses to me.
icon url

Bxofscidad

01/05/11 1:50 PM

#4618 RE: poorgradstudent #4615

Thanks...But



Thanks for the response, but can you explain how Jeffreies can assign a 60% probability of success in the succeed trial and still report that the drug will more likely miss its primary endpoint?


Thanks, Barry